1[1]Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable automatic degibrillator in human beings. N Engl J Med,1980,303: 322-324. 被引量：1
2[2]Gadhok A, Mark Estes Ⅲ NA. Indications for the implantable cardioverter defibrillator. In: Mark Estes Ⅲ ,Manolis AS, Wang PJ, eds. Implantable cardioverter defibrillator. A comprehensive textbook. New York:Marcel Dekker Inc,1994. i87-194. 被引量：1
3[3]Dreifus LS,Fisch C,Griffin JC,et al. For the American college of cardiology/American heart association tast force on assessment of diagnostic and therapeutic cardiovascular procedures(committee on pacemaker implantation).Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Col Cardiol, 1991,18: 1-13. 被引量：1
4[4]Lehmann MH, Salsena S.Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. NASPE Policy Conference Committee.Pacing Clin Electrophysiol, 1991,14:969-979. 被引量：1
5[5]Gregoratos G,Cheitlin MD, Conill A,et al. ACC/AHA guidelines for implantation of cardiac pacemaker and antiarrhythmia devices: Areport of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol, 1998,31:1175-1209. 被引量：1
6[6]Moss AJ,Hall WJ,Cannom DS,et al. Improved survival with an implanted defibrillater in patients with prior myocardial infarction,low ejection fraction and asymptomatic non sustained ventricular tachycardia. N Engl J Med,1996,335: 1933-1940. 被引量：1
7[7]Mushlin AL, Hall WJ, Zwanziger J, et al.The cost-effectiveness of automatic implantable cardiac defibrillators:results form MADIT. Multicenter automatic defibrillatorimplantation trial. Circulation, 1998,97: 2129-2135. 被引量：1
8[8]Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines ).Circulation, 2002.106: 2145-2161. 被引量：1
9[9]Klein H,Auricchio A,Reek S,et al. New primary prevention trials of sudden cardiac dearh in patientas with left ventricular dysfunction: SCD-HeFT and MADIT-Ⅱ. Am J Cardiol, 1999,83: 91D-97D. 被引量：1
10[10]Moss AJ, Zareba W, Hall WJ, et al. Prophylactec implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med,2002,346: 877-882. 被引量：1
5Rocco TP,Dilsizian V,Fischman AJ,et al.Evaluation of ventricular function in patients with coronary artery disease[J].J Nucl Med,1989,30(7):1149-1161. 被引量：1
6Bax JJ,Visser FC,Poldermans D,et al.Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms[J].J Nucl Med,2001,42(1):79-86. 被引量：1
7Wiggers H,Botker HE,Sogaard P,et al.Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy[J].J Am Coll Cardiol,2003,41(5):843-848. 被引量：1
8Germano G,Kiat H,Kavanagh PB,et al.Automatic quantification of ejection fraction from gated myocardial pedusion SPECT[J].J Nucl Med,1995,36(11):2138-2147. 被引量：1
